Sep 30, 2025 04:45PM GeoVax Labs raises $2.3M in registered direct offering

Apr 14, 2025 04:38PM GeoVax (GOVX) ordered to halt work on COVID-19 vaccine project by ATI

Nov 19, 2024 09:01AM Geovax Labs (GOVX) Reports Positive Interim Data Review for Phase 2 Clinical Trial of COVID-19 Vaccine Booster

Nov 12, 2024 09:55PM Geovax Labs Inc. (GOVX) Misses Q3 EPS by 91c

Aug 29, 2024 06:14AM Geovax Labs Inc. (GOVX) Prices 975.61K Share Offering at $5.125/sh

Aug 20, 2024 07:45AM Geovax (GOVX) to Raise Approximately $8.5 Million of Gross Proceeds in Offering

Aug 19, 2024 08:59AM Mpox-linked stocks extend rally into second week

Aug 19, 2024 07:39AM EF Hutton Reiterates Buy Rating on GeoVax Labs Inc. (GOVX)

Aug 14, 2024 01:32PM World Health Organization Declares monkeypox International Emergency

Aug 6, 2024 05:13PM Geovax Labs Inc. (GOVX) Misses Q2 EPS by 199c

Jul 31, 2024 09:00AM Geovax Labs (GOVX) Announces Phase 2 Plans for Gedeptin® Cancer Therapy Following Clinical Advisory Committee Review

Jul 23, 2024 07:01AM EF Hutton Starts GeoVax Labs Inc. (GOVX) at Buy, PT $18

Jul 16, 2024 01:04AM Roth/MKM Starts GeoVax Labs Inc. (GOVX) at Buy

Jul 9, 2024 09:10AM Geovax Labs Inc. (GOVX) Issues H1 2024 Business Update

Jul 2, 2024 06:42AM H.C. Wainwright Reiterates Buy Rating on GeoVax Labs Inc. (GOVX)

Jun 27, 2024 09:11AM Geovax Labs (GOVX) Partners with Allucent for Phase 2b Study of COVID-19 Vaccine Candidate with Funding from BARDA

Jun 18, 2024 07:10AM Geovax Labs Inc. (GOVX) Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the Company's Next-Generation COVID-19 Vaccine Candidate, GEO-CM04S1